Recently, next-generation sequencing has been successfully used to detect mutations in the entire APOB gene in subjects with a clinical diagnosis of FH and no evidence of mutations in LDLR or PCSK9, or in APOB exons 26 and 29 [22]. The gene discussed is PCSK9; the disease is familial hyperaldosteronism.